246 related articles for article (PubMed ID: 31151002)
1. Biomechanics of cultured hepatic cells during different steatogenic hits.
Baldini F; Bartolozzi A; Ardito M; Voci A; Portincasa P; Vassalli M; Vergani L
J Mech Behav Biomed Mater; 2019 Sep; 97():296-305. PubMed ID: 31151002
[TBL] [Abstract][Full Text] [Related]
2. Hepatic lipid droplets: A balancing act between energy storage and metabolic dysfunction in NAFLD.
Mashek DG
Mol Metab; 2021 Aug; 50():101115. PubMed ID: 33186758
[TBL] [Abstract][Full Text] [Related]
3. Modifying nutritional substrates induces macrovesicular lipid droplet accumulation and metabolic alterations in a cellular model of hepatic steatosis.
Gunn PJ; Pramfalk C; Millar V; Cornfield T; Hutchinson M; Johnson EM; Nagarajan SR; Troncoso-Rey P; Mithen RF; Pinnick KE; Traka MH; Green CJ; Hodson L
Physiol Rep; 2020 Jul; 8(13):e14482. PubMed ID: 32643289
[TBL] [Abstract][Full Text] [Related]
4. Genomics of lipid-laden human hepatocyte cultures enables drug target screening for the treatment of non-alcoholic fatty liver disease.
Breher-Esch S; Sahini N; Trincone A; Wallstab C; Borlak J
BMC Med Genomics; 2018 Dec; 11(1):111. PubMed ID: 30547786
[TBL] [Abstract][Full Text] [Related]
5. Models of non-Alcoholic Fatty Liver Disease and Potential Translational Value: the Effects of 3,5-L-diiodothyronine.
Grasselli E; Canesi L; Portincasa P; Voci A; Vergani L; Demori I
Ann Hepatol; 2017; 16(5):707-719. PubMed ID: 28809727
[TBL] [Abstract][Full Text] [Related]
6. Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice.
Takahara I; Akazawa Y; Tabuchi M; Matsuda K; Miyaaki H; Kido Y; Kanda Y; Taura N; Ohnita K; Takeshima F; Sakai Y; Eguchi S; Nakashima M; Nakao K
PLoS One; 2017; 12(3):e0170591. PubMed ID: 28278289
[TBL] [Abstract][Full Text] [Related]
7. A unifying mathematical model of lipid droplet metabolism reveals key molecular players in the development of hepatic steatosis.
Wallstab C; Eleftheriadou D; Schulz T; Damm G; Seehofer D; Borlak J; Holzhütter HG; Berndt N
FEBS J; 2017 Oct; 284(19):3245-3261. PubMed ID: 28763157
[TBL] [Abstract][Full Text] [Related]
8. [Lipid droplet-associated proteins. Importance in steatosis, steatohepatitis and hepatocarcinogenesis].
Straub BK
Pathologe; 2015 Nov; 36 Suppl 2():146-52. PubMed ID: 26400566
[TBL] [Abstract][Full Text] [Related]
9. Lipid droplets disrupt mechanosensing in human hepatocytes.
Chin L; Theise ND; Loneker AE; Janmey PA; Wells RG
Am J Physiol Gastrointest Liver Physiol; 2020 Jul; 319(1):G11-G22. PubMed ID: 32463334
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies.
Baldini F; Khalil M; Bartolozzi A; Vassalli M; Di Ciaula A; Portincasa P; Vergani L
Biomolecules; 2022 May; 12(5):. PubMed ID: 35625660
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of Primary Human Hepatocytes and Hepatoma Cell Lines to Model the Effects of Fatty Acids, Fructose and Glucose on Liver Cell Lipid Accumulation.
Huggett ZJ; Smith A; De Vivo N; Gomez D; Jethwa P; Brameld JM; Bennett A; Salter AM
Nutrients; 2022 Dec; 15(1):. PubMed ID: 36615698
[TBL] [Abstract][Full Text] [Related]
12. Deranged hepatocyte intracellular Ca
Ali ES; Rychkov GY; Barritt GJ
Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
[TBL] [Abstract][Full Text] [Related]
13. Raman spectroscopy analysis of lipid droplets content, distribution and saturation level in Non-Alcoholic Fatty Liver Disease in mice.
Kochan K; Maslak E; Krafft C; Kostogrys R; Chlopicki S; Baranska M
J Biophotonics; 2015 Jul; 8(7):597-609. PubMed ID: 25346221
[TBL] [Abstract][Full Text] [Related]
14. Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis.
Vergani L
Curr Med Chem; 2019; 26(19):3439-3456. PubMed ID: 28521680
[TBL] [Abstract][Full Text] [Related]
15. Molecular imaging analysis of microvesicular and macrovesicular lipid droplets in non-alcoholic fatty liver disease by Raman microscopy.
Minamikawa T; Ichimura-Shimizu M; Takanari H; Morimoto Y; Shiomi R; Tanioka H; Hase E; Yasui T; Tsuneyama K
Sci Rep; 2020 Oct; 10(1):18548. PubMed ID: 33122711
[TBL] [Abstract][Full Text] [Related]
16. A new perspective on NAFLD: Focusing on lipid droplets.
Scorletti E; Carr RM
J Hepatol; 2022 Apr; 76(4):934-945. PubMed ID: 34793866
[TBL] [Abstract][Full Text] [Related]
17. Mitofusin-2 induced by exercise modifies lipid droplet-mitochondria communication, promoting fatty acid oxidation in male mice with NAFLD.
Bórquez JC; Díaz-Castro F; La Fuente FP; Espinoza K; Figueroa AM; Martínez-Ruíz I; Hernández V; López-Soldado I; Ventura R; Domingo JC; Bosch M; Fajardo A; Sebastián D; Espinosa A; Pol A; Zorzano A; Cortés V; Hernández-Alvarez MI; Troncoso R
Metabolism; 2024 Mar; 152():155765. PubMed ID: 38142958
[TBL] [Abstract][Full Text] [Related]
18. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
19. Decreased PEDF Promotes Hepatic Fatty Acid Uptake and Lipid Droplet Formation in the Pathogenesis of NAFLD.
Huang KT; Chen KD; Hsu LW; Kung CP; Li SR; Chen CC; Chiu KW; Goto S; Chen CL
Nutrients; 2020 Jan; 12(1):. PubMed ID: 31968655
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol Ameliorates Lipid Droplet Accumulation in Liver Through a SIRT1/ ATF6-Dependent Mechanism.
Zhou R; Yi L; Ye X; Zeng X; Liu K; Qin Y; Zhang Q; Mi M
Cell Physiol Biochem; 2018; 51(5):2397-2420. PubMed ID: 30537742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
